布卡武（刚果民主共和国东部城市）医护人员中高 SARS-CoV-2 血清流行率。
High SARS-CoV-2 Seroprevalence in Healthcare Workers in Bukavu, Eastern Democratic Republic of Congo.
机构信息
1Gynaecology and General Surgery, Panzi General Referral Hospital, Bukavu, Democratic Republic of Congo.
2Faculty of Medicine, Evangelical University in Africa, Bukavu, Democratic Republic of Congo.
出版信息
Am J Trop Med Hyg. 2021 Feb 16;104(4):1526-1530. doi: 10.4269/ajtmh.20-1526.
Abstract
Among 359 healthcare workers (HCW) employed in Panzi General Referral Hospital located in Bukavu in the Democratic Republic of Congo, 148 (41.2%) tested positive for SARS-CoV-2 antibodies. Thirty-three (22.3%) of the 148 personnel with positive serology reported symptoms evoking a prior COVID-19 illness. None of the infected HCWs reported COVID-related hospitalization, and all of them recovered. Our findings indicate high and underestimated circulation of SARS-CoV-2 within the Bukavu area.
摘要
在刚果民主共和国布卡武的潘齐综合转诊医院的 359 名医护人员中，有 148 人（41.2%）的 SARS-CoV-2 抗体检测呈阳性。在 148 名血清学检测呈阳性的人员中，有 33 人（22.3%）报告出现提示先前 COVID-19 疾病的症状。没有感染的医护人员报告与 COVID 相关的住院治疗，且他们均已康复。我们的发现表明 SARS-CoV-2 在布卡武地区广泛传播且感染情况被低估。
相似文献
1
High SARS-CoV-2 Seroprevalence in Healthcare Workers in Bukavu, Eastern Democratic Republic of Congo.
Am J Trop Med Hyg. 2021 Feb 16;104(4):1526-1530. doi: 10.4269/ajtmh.20-1526.
2
[Seroprevalence of SARS-CoV-2 antibodies among travellers and workers screened at the Saint Luc Clinic in Bukavu, a city in eastern Democratic Republic of the Congo, from May to August 2020].
Pan Afr Med J. 2021 Jan 27;38:93. doi: 10.11604/pamj.2021.38.93.26663. eCollection 2021.
3
COVID-19 seroprevalence cohort survey among health care workers and their household members in Kinshasa, DR Congo, 2020-2022.
J Health Popul Nutr. 2024 Jun 1;43(1):74. doi: 10.1186/s41043-024-00536-0.
4
Seroprevalence of anti-SARS-CoV-2 antibodies and risk of viral exposure among healthcare workers in the South Kivu province, eastern Democratic Republic of the Congo: a cross-sectional study.
BMJ Open. 2024 Jan 4;14(1):e072212. doi: 10.1136/bmjopen-2023-072212.
5
Seroprevalence of COVID-19 infection in a densely populated district in the eastern Democratic Republic of Congo.
Epidemiol Infect. 2023 Feb 1;151:e24. doi: 10.1017/S0950268823000158.
6
SARS-CoV-2 seroprevalence in healthcare workers in a tertiary healthcare network in Victoria, Australia.
Infect Dis Health. 2021 Aug;26(3):208-213. doi: 10.1016/j.idh.2021.03.004. Epub 2021 Apr 13.
7
Prevalence of anti-SARS-CoV-2 antibodies in people attending the two main Goma markets in the eastern Democratic Republic of the Congo.
Epidemiol Infect. 2023 Sep 19;151:e167. doi: 10.1017/S0950268823001498.
8
Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers.
Epidemiol Infect. 2021 Apr 27;149:e157. doi: 10.1017/S0950268821000984.
9
Incidence of Coronavirus Disease 2019 (COVID-19) among healthcare workers during the first and second wave in the Democratic Republic of the Congo: a descriptive study.
BMC Infect Dis. 2023 Aug 8;23(1):519. doi: 10.1186/s12879-023-08494-4.
10
Cross-sectional prevalence of SARS-CoV-2 antibodies in healthcare workers in paediatric facilities in eight countries.
J Hosp Infect. 2021 Apr;110:60-66. doi: 10.1016/j.jhin.2020.12.019. Epub 2021 Jan 7.
引用本文的文献
1
SARS-CoV-2 infection rates and associated risk factors in healthcare workers: systematic review and meta-analysis.
Sci Rep. 2025 Feb 8;15(1):4705. doi: 10.1038/s41598-025-89472-5.
2
COVID-19 seroprevalence cohort survey among health care workers and their household members in Kinshasa, DR Congo, 2020-2022.
J Health Popul Nutr. 2024 Jun 1;43(1):74. doi: 10.1186/s41043-024-00536-0.
3
High seroprevalence of severe acute respiratory syndrome coronavirus 2 among healthcare workers in Yaoundé, Cameroon after the first wave of Covid-19 pandemic and associated factors.
Influenza Other Respir Viruses. 2024 Feb;18(2):e13239. doi: 10.1111/irv.13239.
4
Magnitude and Durability of the Antibody Response to mRNA-Based Vaccination Among SARS-CoV-2 Seronegative and Seropositive Health Care Personnel.
Open Forum Infect Dis. 2024 Jan 19;11(1):ofae009. doi: 10.1093/ofid/ofae009. eCollection 2024 Jan.
5
Seroprevalence of anti-SARS-CoV-2 antibodies and risk of viral exposure among healthcare workers in the South Kivu province, eastern Democratic Republic of the Congo: a cross-sectional study.
BMJ Open. 2024 Jan 4;14(1):e072212. doi: 10.1136/bmjopen-2023-072212.
6
Rapid antigen test as a screening tool for SARS-CoV-2 infection: Head-to-head comparison with qRT-PCR in Ethiopia.
Heliyon. 2023 Dec 9;10(1):e23518. doi: 10.1016/j.heliyon.2023.e23518. eCollection 2024 Jan 15.
7
Estimating the number of probable new SARS-CoV-2 infections among tested subjects from the number of confirmed cases.
BMC Med Res Methodol. 2023 Nov 17;23(1):272. doi: 10.1186/s12874-023-02077-2.
8
Risk assessment and antibody responses to SARS-CoV-2 in healthcare workers.
Front Public Health. 2023 Jul 21;11:1164326. doi: 10.3389/fpubh.2023.1164326. eCollection 2023.
9
High seroprevalence of antibodies against SARS-CoV-2 among healthcare workers 8 months after the first wave in Aden, Yemen.
PLOS Glob Public Health. 2022 Nov 9;2(11):e0000767. doi: 10.1371/journal.pgph.0000767. eCollection 2022.
10
Rural prioritization may increase the impact of COVID-19 vaccines in a representative COVAX AMC country setting due to ongoing internal migration: A modeling study.
PLOS Glob Public Health. 2022 Jan 27;2(1):e0000053. doi: 10.1371/journal.pgph.0000053. eCollection 2022.
Zotero 插件